x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

MedTech Global Insights

What"s next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you"re an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.

science life sciences

All Episodes

02:21

Pure Global: USA's QMSR Shift, The ISO 13485 Gamble...

MedTech Global Insights ·

2026/02/23

The U.S. FDA has just enacted its most significant regulatory overhaul in decades, replacing the old Quality System Regulation (QSR) with the new Quality Management System Regulation (QMSR). This major shift harmonizes the FDA's framework with the international ISO 13485 standard, a move intended to streamline global compliance. However, this change introduces immediate and critical challenges for medical device manufacturers worldwide. This episode of MedTech Global Insights dives deep into what

en

02:12

USA MedTech: Pure Global on The FDA's 'Forever Audit'...

MedTech Global Insights ·

2026/02/22

The game has changed. This week, the US FDA implemented a 'Total Product Life Cycle' inspection model, shifting regulatory focus from a one-time market approval to a continuous, career-long scrutiny of your medical device. This episode of MedTech Global Insights breaks down what this means for manufacturers and why your old compliance strategies are no longer enough.We explore the practical consequences of this shift. Imagine your device has been on the market for seven years. Are you prepared for

en

02:10

Pure Global: USA QMSR Deadline & The Hidden Gaps...

MedTech Global Insights ·

2026/02/21

This episode of MedTech Global Insights dives into the critical February 2026 deadline for the FDA's new Quality Management System Regulation (QMSR). We explore why this major regulatory shift is more than just an alignment with the ISO 13485 international standard. We reveal the hidden complexities and specific FDA requirements that are catching many MedTech companies off guard. Discover why simply having an ISO 13485 certificate is not enough to ensure compliance and avoid costly delays or

en

01:43

USA Cybersecurity: The FDA's RTA Threat. A Pure...

MedTech Global Insights ·

2026/02/20

Last week, the FDA sent a clear message to the MedTech industry by halting a major device submission over cybersecurity flaws. This episode of MedTech Global Insights dissects the new reality of the FDA's "Refuse to Accept" policy and what it means for manufacturers. We go beyond the headlines to reveal the specific requirements that are now non-negotiable for market approval in the United States.This is a fundamental shift in regulatory enforcement, where a weak cybersecurity plan can completely

en

02:01

Pure Global: USA MedTech Cybersecurity & Its Hidden...

MedTech Global Insights ·

2026/02/19

The FDA's new cybersecurity rules are more than just a regulatory checklist; they're reshaping the landscape for MedTech investment and acquisitions. Many innovative startups are discovering that their market access and company valuation now hinge entirely on their cybersecurity preparedness, an area they may have overlooked.This episode of MedTech Global Insights explores the immediate business impact of these stringent new requirements. We uncover why a lack of cybersecurity documentation is

en

01:38

USA's AI MedTech: Pure Global on The New FDA...

MedTech Global Insights ·

2026/02/18

This week, we dissect the FDA's groundbreaking new draft guidance on AI/ML-enabled medical devices. This isn't just another regulation. it's a paradigm shift that redefines the rules for software as a medical device. We explore how the requirement for a "Predetermined Change Control Plan" (PCCP) is creating significant new hurdles for innovators in the MedTech space.We break down what this means for manufacturers, from startups to enterprise leaders. For instance, a company with a brilliant,

en

01:50

USA's AI Diagnostics: Pure Global on FDA's Hidden...

MedTech Global Insights ·

2026/02/17

This week on MedTech Global Insights, we dissect the FDA's surprising new focus on AI-powered medical devices. A recent public enforcement action has sent a clear message: pre-market approval is no longer enough. The agency is now intensely scrutinizing the hidden risks of post-market cybersecurity and algorithm performance. We break down what this regulatory shift means for MedTech innovators worldwide. From the challenge of 'data drift' to the unseen vulnerabilities in routine software updates,

en

01:59

Boston's Neurovascular Gambit: Pure Global on M&A Chaos

MedTech Global Insights ·

2026/02/16

In this episode, we dissect the massive acquisition of Penumbra by Boston Scientific. We go beyond the financial headlines to explore the immense, unseen regulatory and logistical challenges that lie ahead as these two MedTech giants merge their global operations. This is not just a story of market consolidation; it is a case study in navigating the treacherous waters of international compliance. The real challenge begins now: How does Boston Scientific integrate Penumbra's product portfolio across

en

02:01

Brussels' IVDR Reprieve: Pure Global on Navigating...

MedTech Global Insights ·

2026/02/15

The European Commission has just proposed another extension to the challenging IVDR transition deadlines, granting diagnostic manufacturers critical breathing room. In this episode, we break down what these new dates mean and analyze the systemic crisis that made this delay necessary.This is not a simple postponement. it's a reaction to the severe shortage of Notified Bodies and the real risk of essential medical tests vanishing from the European market. We explore the strategic decisions that

en

01:57

Pure Global: US QMSR - The End of MedTech's Boardroom...

MedTech Global Insights ·

2026/02/14

This week, MedTech Global Insights dives into the historic shift in FDA regulation that took effect on February 2, 2026. The new Quality Management System Regulation (QMSR) aligns U.S. standards with the global ISO 13485 benchmark, fundamentally altering the landscape for every medical device manufacturer operating in the United States. We break down the most critical change: the new level of transparency required during FDA audits. Previously shielded internal documents, including candid

en

01:56

Pure Global: US LDT Rule, A Diagnostic World's Unseen...

MedTech Global Insights ·

2026/02/13

In a landmark decision, the U.S. FDA has finalized its rule to regulate Laboratory Developed Tests (LDTs) as medical devices, ending decades of enforcement discretion. This episode of MedTech Global Insights unpacks the immediate and long-term consequences of this industry-altering shift. We explore why the FDA made this move, what it means for clinical labs, and how it redraws the competitive map for diagnostic innovators.This isn't just a policy update; it's a fundamental change that will create

en

02:18

Pure Global: US MedTech Cybersecurity's SBOM Reckoning

MedTech Global Insights ·

2026/02/12

A recent cybersecurity breach at a major US hospital, targeting connected infusion pumps, has sent shockwaves through the MedTech industry. The incident, which triggered a joint alert from the FDA and CISA, highlights the critical vulnerabilities that exist even in trusted medical devices and the immense pressure now on manufacturers.This episode of MedTech Global Insights unpacks the event and explores the new reality of cybersecurity compliance. We discuss the stringent new requirements from the

en

01:52

USA's LDT Shake-Up: Pure Global on Navigating FDA's...

MedTech Global Insights ·

2026/02/11

The U.S. FDA has finalized its rule to regulate Laboratory Developed Tests (LDTs) as medical devices, ending a long-standing policy of enforcement discretion. This episode of MedTech Global Insights breaks down one of the most significant regulatory shifts in the diagnostics industry in decades. We explore the immediate, practical consequences for clinical laboratories, from new compliance burdens to critical strategic decisions.We move beyond the headlines to examine what this means on the

en

01:46

Hong Kong's AI MedTech: Pure Global on The New...

MedTech Global Insights ·

2026/02/10

This episode of MedTech Global Insights dives into the increasingly fragmented world of AI medical device regulation. As innovative technologies surge, global markets are responding with unique, localized rules, creating complex challenges for manufacturers. We explore the latest developments and what they mean for your global strategy.We spotlight a critical new case: Hong Kong's recently released guidance on AI medical devices. For a company with an FDA-approved diagnostic tool, this new

en

02:06

US MedTech's New Test: Pure Global on the FDA's TPLC...

MedTech Global Insights ·

2026/02/09

This week, the US FDA overhauled its inspection strategy, introducing a "Total Product Life Cycle" (TPLC) approach. This episode of MedTech Global Insights breaks down what this seismic shift means for medical device manufacturers. We move beyond the headlines to explain how the FDA is breaking down traditional compliance silos, demanding a single, unified view of a product from conception to obsolescence. We explore the practical challenges this creates for companies with fragmented data systems

en

02:31

US FDA Quality System Overhaul: Pure Global on Life...

MedTech Global Insights ·

2026/02/08

In a landmark decision, the US FDA has finalized its rule to replace the decades-old Quality System Regulation with the new Quality Management System Regulation (QMSR). This historic move aligns US medical device standards with the international ISO 13485, marking a significant step towards global harmonization. But this is not a simple copy-and-paste of the global standard.This episode breaks down the critical details of this regulatory shift. We explore why being ISO 13485 certified is not

en

01:50

Pure Global: US LDTs, the FDA's Regulatory Wake-Up Call

MedTech Global Insights ·

2026/02/07

The U.S. FDA has just upended the diagnostics world. After decades of operating in a regulatory gray area, laboratory-developed tests (LDTs) will now be regulated as medical devices. This episode of MedTech Global Insights dives deep into what this massive policy shift means for labs, patients, and the entire MedTech industry. We explore the end of the FDA's "enforcement discretion" policy and the beginning of a new era of compliance. We unpack the immense operational and financial challenges

en

02:23

USA SaMD & The RWE Paradox: A Pure Global Briefing

MedTech Global Insights ·

2026/02/06

This week, we dissect the FDA's sudden and impactful new guidance on Real-World Evidence (RWE) that just sent ripples through the US digital health sector. This isn't just another update; it's a fundamental shift in how data from wearables and EHRs will be scrutinized, potentially derailing existing regulatory strategies for countless SaMD and AI-driven medical devices.We explore the new, stricter demands for data integrity and what it means for companies that have banked their futures on the

en

01:46

US SaMD Shakedown: Pure Global on FDA's Guidance Void

MedTech Global Insights ·

2026/02/05

The U.S. FDA has unexpectedly withdrawn its key guidance on clinical evaluation for Software as a Medical Device (SaMD). This sudden move has created significant uncertainty for digital health and AI technology developers, leaving many to question if their existing product validation strategies are still viable. This episode of MedTech Global Insights breaks down the immediate impact of this regulatory shift. We explore what this "guidance void" means for companies preparing for FDA submission and

en

02:06

Pure Global: US QMSR & The ISO 13485 Compliance Traps

MedTech Global Insights ·

2026/02/04

The FDA's new Quality Management System Regulation (QMSR) is finally here, aligning US regulations with the global ISO 13485 standard. While this promises streamlined compliance for manufacturers, it also introduces subtle but critical new challenges.This episode goes beyond the surface-level news of harmonization. We uncover the dangerous assumption that existing ISO 13485 certification equals automatic QMSR compliance and highlight the specific gaps that could lead to inspection failures. A

en

239 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter